US › Healthcare

High Tide Inc (HITI)

US · Healthcare · Pharmaceutical Retailers

$2.25+4.65%
Last close · 2026-08-04

Latest quarter · ended 2026-04-30

Revenue
$179.3M
Revenue YoY
+30.1%
Net profit
$-197,000
Profit YoY
+93.2%
EPS
$0.01
EPS estimate
$-0.02
Net margin
-0.1%

EPS came in at 0.01 against a street estimate of -0.02 — a beat of 150.0%.

Key statistics

Market cap
$186.3M
Forward P/E
16.5
P/B
2.95
Book value
$0.72
EPS (TTM)
$-0.38
52-week high
$4.06
52-week low
$2.02
50-day MA
$2.27
200-day MA
$2.52
Beta
1.05

Analyst view

Analysts rate High Tide Inc a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $4.67.

Shareholding

Insiders
12.31%
Institutions
10.06%

Largest institutional holders

FundStake
Tidal Investments LLC.1.95%
AdvisorShares Investments, LLC1.51%
Renaissance Technologies Corp1.22%
Two Sigma Investments LLC0.62%
Millennium Management LLC0.41%
Bank of America Corp0.39%
Walleye Trading Advisors, LLC0.35%
Federation des caisses Desjardins du Quebec0.29%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for High Tide Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.